{
    "nctId": "NCT04309929",
    "briefTitle": "Description of the Analgesia Obtained With the Anesthesiological Protocols Currently Used in Breast Surgery",
    "officialTitle": "Description of the Analgesia Obtained With the Anesthesiological Protocols Currently Used in Breast Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Assessment of the change of level of anesthesia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female gender\n* Age\\> 18 years;\n* Patients in ASA class \\<4;\n* Planned mastectomy surgery, simple mastectomy with immediate reconstruction, mastectomy with sentinel-lymph node biopsy, modified radical mastectomy (unilateral or bilateral);\n* Absence of allergies or hypersensitivity reported and / or documented to drugs used routinely for post-operative analgesia;\n* Absence of inflammatory changes at the surgical site level;\n* Presence of the patient's informed consent to the processing of personal data;\n\nExclusion Criteria:\n\n* Known alterations of coagulation;\n* Known cardiac arrhythmias (atrial sinus block I, II, III type, atrioventricular block I, II and III type);\n* Documented renal failure (patient undergoing renal replacement therapy, or creatininemia \u2265 2 mg / dl);\n* Severe hepatic insufficiency (Child-Plugh class III and IV); Seizure states (absences, seizures of large and / or small epileptic disease);\n* Respiratory failure (PaO2 \u2264 60mmHg PaCO2\u2265 50mmHg);",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}